Literature DB >> 25193656

Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: association with disease progression and influence of immune pressure.

Jaclyn K Mann1, Denis Chopera2, Saleha Omarjee1, Xiaomei T Kuang3, Anh Q Le4, Gursev Anmole3, Ryan Danroth4, Philip Mwimanzi4, Tarylee Reddy5, Jonathan Carlson6, Mopo Radebe1, Philip J R Goulder7, Bruce D Walker8, Salim Abdool Karim9, Vladimir Novitsky10, Carolyn Williamson11, Mark A Brockman12, Zabrina L Brumme13, Thumbi Ndung'u14.   

Abstract

Nef plays a major role in HIV-1 pathogenicity. We studied HIV-1 subtype C infected individuals in acute/early (n = 120) or chronic (n = 207) infection to investigate the relationship between Nef-mediated CD4/HLA-I down-regulation activities and disease progression, and the influence of immune-driven sequence variation on these Nef functions. A single Nef sequence per individual was cloned into an expression plasmid, followed by transfection of a T cell line and measurement of CD4 and HLA-I expression. In early infection, a trend of higher CD4 down-regulation ability correlating with higher viral load set point was observed (r = 0.19, p = 0.05), and higher HLA-I down-regulation activity was significantly associated with faster rate of CD4 decline (p = 0.02). HLA-I down-regulation function correlated inversely with the number HLA-associated polymorphisms previously associated with reversion in the absence of the selecting HLA allele (r = -0.21, p = 0.0002). These data support consideration of certain Nef regions in HIV-1 vaccine strategies designed to attenuate the infection course.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD4 down-regulation; HIV-1 Nef; HIV-1 disease progression; HIV-1 subtype C; HLA-I down-regulation; HLA-associated polymorphisms; Immune evasion

Mesh:

Substances:

Year:  2014        PMID: 25193656      PMCID: PMC4252354          DOI: 10.1016/j.virol.2014.08.009

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  55 in total

1.  Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Elias Woldegabriel; Lemme Kebaabetswe; Raabya Rossenkhan; Busisiwe Mlotshwa; Caitlin Bonney; Mariel Finucane; Rosemary Musonda; Sikhulile Moyo; Carolyn Wester; Erik van Widenfelt; Joseph Makhema; Stephen Lagakos; M Essex
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

2.  A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef.

Authors:  Marjon Navis; Ingrid M M Schellens; Peter van Swieten; José A M Borghans; Frank Miedema; Neeltje A Kootstra; Debbie van Baarle; Hanneke Schuitemaker
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226

3.  Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.

Authors:  Mark A Brockman; Arne Schneidewind; Matthew Lahaie; Aaron Schmidt; Toshiyuki Miura; Ivna Desouza; Faina Ryvkin; Cynthia A Derdeyn; Susan Allen; Eric Hunter; Joseph Mulenga; Paul A Goepfert; Bruce D Walker; Todd M Allen
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

4.  Central role of reverting mutations in HLA associations with human immunodeficiency virus set point.

Authors:  Philippa C Matthews; Andrew Prendergast; Alasdair Leslie; Hayley Crawford; Rebecca Payne; Christine Rousseau; Morgane Rolland; Isobella Honeyborne; Jonathan Carlson; Carl Kadie; Christian Brander; Karen Bishop; Nonkululeko Mlotshwa; James I Mullins; Hoosen Coovadia; Thumbi Ndung'u; Bruce D Walker; David Heckerman; Philip J R Goulder
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

5.  Evolution of proviral gp120 over the first year of HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Stephen Lagakos; Michaela Herzig; Caitlin Bonney; Lemme Kebaabetswe; Raabya Rossenkhan; David Nkwe; Lauren Margolin; Rosemary Musonda; Sikhulile Moyo; Elias Woldegabriel; Erik van Widenfelt; Joseph Makhema; M Essex
Journal:  Virology       Date:  2008-10-29       Impact factor: 3.616

6.  Functional adaptation of Nef to the immune milieu of HIV-1 infection in vivo.

Authors:  Martha J Lewis; Arumugam Balamurugan; Ayako Ohno; Stephanie Kilpatrick; Hwee L Ng; Otto O Yang
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

7.  Timing constraints of in vivo gag mutations during primary HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Rui Wang; Lauren Margolin; Jeannie Baca; Lemme Kebaabetswe; Raabya Rossenkhan; Caitlin Bonney; Michaela Herzig; David Nkwe; Sikhulile Moyo; Rosemary Musonda; Elias Woldegabriel; Erik van Widenfelt; Joseph Makhema; Stephen Lagakos; M Essex
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

8.  Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.

Authors:  Hayley Crawford; Wendy Lumm; Alasdair Leslie; Malinda Schaefer; Debrah Boeras; Julia G Prado; Jianming Tang; Paul Farmer; Thumbi Ndung'u; Shabir Lakhi; Jill Gilmour; Paul Goepfert; Bruce D Walker; Richard Kaslow; Joseph Mulenga; Susan Allen; Philip J R Goulder; Eric Hunter
Journal:  J Exp Med       Date:  2009-03-23       Impact factor: 14.307

9.  Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication.

Authors:  Arne Schneidewind; Mark A Brockman; Ruifeng Yang; Rahma I Adam; Bin Li; Sylvie Le Gall; Charles R Rinaldo; Sharon L Craggs; Rachel L Allgaier; Karen A Power; Thomas Kuntzen; Chang-Shung Tung; Montiago X LaBute; Sandra M Mueller; Thomas Harrer; Andrew J McMichael; Philip J R Goulder; Christopher Aiken; Christian Brander; Anthony D Kelleher; Todd M Allen
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

10.  Crippling HIV one mutation at a time.

Authors:  Todd M Allen; Marcus Altfeld
Journal:  J Exp Med       Date:  2008-05-05       Impact factor: 14.307

View more
  12 in total

1.  Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.

Authors:  Marion W Kiguoya; Jaclyn K Mann; Denis Chopera; Kamini Gounder; Guinevere Q Lee; Peter W Hunt; Jeffrey N Martin; T Blake Ball; Joshua Kimani; Zabrina L Brumme; Mark A Brockman; Thumbi Ndung'u
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  Nef-mediated inhibition of NFAT following TCR stimulation differs between HIV-1 subtypes.

Authors:  Lisa Naidoo; Zinhle Mzobe; Steven W Jin; Erasha Rajkoomar; Tarylee Reddy; Mark A Brockman; Zabrina L Brumme; Thumbi Ndung'u; Jaclyn K Mann
Journal:  Virology       Date:  2019-02-21       Impact factor: 3.616

3.  A Novel HIV-1 Nef Mutation in a Primary Pediatric Isolate Impairs MHC-Class I Downregulation and Cytopathicity.

Authors:  Ayub Ali; Robert L Furler; Livia Pedroza-Martins; Arnaud D Colantonio; Deborah Anisman-Posner; Yvonne Bryson; Otto O Yang; Christel H Uittenbogaart
Journal:  AIDS Res Hum Retroviruses       Date:  2019-11-04       Impact factor: 2.205

4.  HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.

Authors:  Zachary Ende; Martin J Deymier; Daniel T Claiborne; Jessica L Prince; Daniela C Mónaco; William Kilembe; Susan A Allen; Eric Hunter
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

5.  Genome-wide association study reveals genetic variants associated with HIV-1C infection in a Botswana study population.

Authors:  Andrey K Shevchenko; Daria V Zhernakova; Sergey V Malov; Alexey Komissarov; Sofia M Kolchanova; Gaik Tamazian; Alexey Antonik; Nikolay Cherkasov; Sergey Kliver; Anastasiia Turenko; Mikhail Rotkevich; Igor Evsyukov; David Vlahov; Prisca K Thami; Simani Gaseitsiwe; Vladimir Novitsky; Myron Essex; Stephen J O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-23       Impact factor: 12.779

6.  TE-domestication and horizontal transfer in a putative Nef-AP1mu mimic of HLA-A cytoplasmic domain re-trafficking.

Authors:  Joseph S Murray; Elaina H Murray
Journal:  Mob Genet Elements       Date:  2016-04-12

7.  Modelling and in vitro testing of the HIV-1 Nef fitness landscape.

Authors:  John P Barton; Erasha Rajkoomar; Jaclyn K Mann; Dariusz K Murakowski; Mako Toyoda; Macdonald Mahiti; Phillip Mwimanzi; Takamasa Ueno; Arup K Chakraborty; Thumbi Ndung'u
Journal:  Virus Evol       Date:  2019-08-05

8.  Defective HIV-1 proviruses produce viral proteins.

Authors:  Hiromi Imamichi; Mindy Smith; Joseph W Adelsberger; Taisuke Izumi; Francesca Scrimieri; Brad T Sherman; Catherine A Rehm; Tomozumi Imamichi; Alice Pau; Marta Catalfamo; Anthony S Fauci; H Clifford Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-06       Impact factor: 11.205

9.  Genetic determinants of Nef-mediated CD4 and HLA class I down-regulation differences between HIV-1 subtypes B and C.

Authors:  Jaclyn K Mann; Saleha Omarjee; Phumzile Khumalo; Thumbi Ndung'u
Journal:  Virol J       Date:  2015-11-25       Impact factor: 4.099

10.  Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa.

Authors:  Colin M Venner; Immaculate Nankya; Fred Kyeyune; Korey Demers; Cynthia Kwok; Pai-Lien Chen; Sandra Rwambuya; Marshall Munjoma; Tsungai Chipato; Josaphat Byamugisha; Barbara Van Der Pol; Peter Mugyenyi; Robert A Salata; Charles S Morrison; Eric J Arts
Journal:  EBioMedicine       Date:  2016-10-12       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.